Bausch Health (MEX:BHCN) Valuation Rank


MEX:BHCN Bausch Health Companies Inc MEX:BHCN
48 GF Score
Price MXN85.44
GF Value MXN188.23
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Bausch Health Valuation Rank Related Terms

MEX:BHCN
48GF Score
Bausch Health Companies Inc MEX:BHCN
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bausch Health (MEX:BHCN) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of MXN85.44 is trading 54.6% below its estimated GF Value™ of MXN188.23. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for MEX:BHCN:

  • Valuation Rank:
  • GF Value™: MXN188.23 vs. price of MXN85.44 (54.6% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the MEX:BHCN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
48GF Score

Get the complete analysis for MEX:BHCN

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN85.44
Price
MXN188.23
GF Value